Table 1

Demographic and clinical characteristics of the two outcomes groups in CVST patients

Variable	Total	Good (187, 82.0%)	Poor (41, 18.0%)	P values
Age	35.2±13.2	33.8±12.7	41.9±13.8	0.001*
Gender	228	187	41	0.505
Female	134	108	26
Male	94	79	15
From onset to admission time	78.9±333.3	78.0±358.4	83.4±182.4	>0.1
Malignancy	8	5	3	0.143
Infection	71	57	14	0.854
Pregnancy or puerperium	45	39	6	0.516
Haematological diseases	8	6	2	0.637
Rheumatic diseases	2	1	1	0.328
Renal disease	4	3	1	0.550
Fatigue	15	15	0	0.079
Trauma	6	5	1	0.932
Intracerebral haemorrhage	37	23	14	0.001*
Epilepsy	44	35	9	0.635
Dyskinesia and sensory disturbance	35	27	8	0.414
Coma	41	23	18	<0.01*
Barylalia	7	6	1	0.796
Isolated headache	26	24	2	0.147
Intracranial hypertension	166	135	31	0.656
Lymphocyte	1.6±0.6	1.7±0.7	1.1±0.4	<0.01*
Monocyte	0.7±0.3	0.6±0.3	0.6±0.3	0.788
LMR	3.1±1.7	3.2±1.8	2.3±1.2	<0.01*
D-dimer	2.0±4.8	1.5±2.4	4.1±9.8	0.001*
Left sigmoid sinus	71	61	10	0.303
Right sigmoid sinus	75	64	11	0.361
Left transverse sinus	97	78	19	0.587
Right transverse sinus	97	80	17	0.877
Straight sinus	50	31	19	<0.01*
Superior sagittal sinus	149	123	26	0.774
Inferior sagittal sinus	25	17	8	0.053
Venous	26	17	9	0. 019*